The Apolipoprotein E (APOE) gene encodes for three isoforms in the human population (APOE2, APOE3 and APOE4). Whereas the role of APOE in lipid metabolism is well characterized, the specific metabolic signatures of the APOE isoforms during metabolic disorders, remain unclear. OBJECTIVE: To elucidate the molecular underpinnings of APOE-directed metabolic alterations, we tested the hypothesis that APOE4 drives a whole-body metabolic shift toward increased lipid oxidation. METHODS: We employed humanized mice in which the Apoe gene has been replaced by the human APOE*3 or APOE*4 allele to produce human APOE3 or APOE4 proteins and characterized several mechanisms of fatty-acid oxidation, lipid storage, substrate utilization and thermogenesis in those mice. RESULTS: We show that, whereas APOE4 mice gained less body weight and mass than their APOE3 counterparts on a Western-type diet (P o0.001), they displayed elevated insulin and homeostatic model assessment, markers of insulin resistance (P = 0.004 and P = 0.025, respectively). APOE4 mice also demonstrated a reduced respiratory quotient during the postprandial period (0.95 ± 0.03 versus 1.06 ± 0.03, Po 0.001), indicating increased usage of lipids as opposed to carbohydrates as a fuel source. Finally, APOE4 mice showed increased body temperature (37.30 ± 0.68 versus 36.9 ± 0.58°C, P = 0.039), augmented cold tolerance and more metabolically active brown adipose tissue compared with APOE3 mice. CONCLUSION: These data suggest that APOE4 mice may resist weight gain via an APOE4-directed global metabolic shift toward lipid oxidation and enhanced thermogenesis, and may represent a critical first step in the development of APOE-directed therapies for a large percentage of the population affected by disorders with established links to APOE and metabolism.
INTRODUCTION
Apolipoprotein E (APOE) associates with lipoproteins and mediates their receptor binding, thereby having a paramount role in lipid metabolism. In humans, the APOE gene is polymorphic and has three alleles, APOE*2, *3 and *4. 1 A wealth of studies show that plasma lipids are higher in individuals who carry an APOE*4 allele (15-20% of the population) when compared with individuals with only APOE*3 alleles. 2 In addition to hyperlipidemia, APOE*4 has also been linked to metabolic syndrome and impaired ability to properly manage postprandial glucose and carbohydrates. [3] [4] [5] Interestingly, impaired glucose metabolism in the brain is a hallmark of Alzheimer's disease (AD), 6 and the APOE*4 allele is associated with reduced neuronal glucose utilization 7 and increased risk of developing AD. 8 Obesity, defined as a pathological expansion of white adipose tissue (WAT), is associated with higher levels of fasting insulin and glucose in the plasma. 9 In addition to its lipid-storing capacity, adipose tissue represents a highly active endocrine and metabolic organ. 10 The presence of a dysfunctional adipose depot is a metabolic complication that increases the risk of developing insulin resistance (IR), metabolic syndrome and type 2 diabetes, and is closely linked to disturbances in lipid and glucose metabolism. 11 We have previously provided evidence in mice 12, 13 and humans, 5, 14 suggesting that APOE has an important role in WAT function. However, the specific metabolic signatures of the APOE isoforms-and their pathophysiological contributions during obesity-remain unclear. Given the current epidemic of obesity, elucidating the molecular underpinnings of APOE-directed metabolic alterations has become a critical step toward the development of targeted therapies for disorders ranging from metabolic syndrome to AD.
In the current study we employed humanized mice in which the Apoe gene has been replaced by the human APOE*3 or APOE*4 allele to produce human APOE3 or APOE4 proteins at physiological levels. 15 We aimed to characterize the energy balance phenotype of these mice with human APOE in regards to weight gain, body composition, adipose tissue physiology, glucose homeostasis, energy utilization and thermogenesis. Here, we show that when compared to mice with APOE3, the presence of APOE4 in mice alters the global metabolic profile with a shift toward fatty-acid oxidation and increased BAT-mediated thermogenesis.
MATERIALS AND METHODS Mice
Mice homozygous for replacement of the endogenous Apoe gene with the human APOE*3 (APOE3) or APOE*4 (APOE4) allele were backcrossed onto a C57BL/6 genetic background. 15 Leptin deficient (ob/ob) mice on a C57BL/6 genetic background were purchased from Jackson Laboratories (B6.CgLepob/J; Jackson Laboratories, Bar Harbor, ME, USA). Mice heterozygous for leptin deficiency (ob/+) were crossed to human APOE mice and bred to produce mice homozygous for leptin deficiency (ob/ob) and homozygous for human APOE. Male mice were fed ad libitum either regular chow containing 5.3% fat and 0.019% cholesterol (Prolab Isopro RMH 3000, ref 5P76; Agway Inc., Syracuse, NY, USA) or a high-fat Western-type diet (WD) containing 21% (w/w) fat and 0.2% (w/w) cholesterol (TD88137; Teklad, Madison, WI, USA) over the period indicated in each experiment. All procedures complied with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and with IACUC approval at the University of North Carolina and at Oregon Health and Sciences University.
Indirect calorimetry
Mice were housed in a comprehensive lab animal-monitoring system (CLAMS; Columbus Instruments International Corporation, Columbus, OH, USA). Following a 24-h acclimation period, mice were monitored for 24 h for O 2 consumption, CO 2 production and respiratory exchange ratio (RER; RER = vCO 2 /vO 2 , where v is volume). Mice were fed ad libitum regular chow. Horizontal and vertical activity was determined by counting the number of successive beam breaks over 15 min using infrared photo beams.
Biochemical and metabolic assays
After a 4-h fast, animals were anesthetized with 2,2,2-tribromoethanol and their blood was collected. Plasma glucose, cholesterol, free fatty acids and total ketone bodies were measured using commercial kits (Wako, Richmond, VA, USA). Triglycerides (TGs), insulin and lactate were determined using commercial kits from Stanbio (Boerne, TX, USA), Crystal Chem Inc. (Downers Grove, IL, USA) and Sigma-Aldrich (St Louis, MO, USA), respectively. Feces were freeze-dried and mechanically homogenized, and fecal TG determined as above. Protein expression levels were analyzed by western blot using antibodies against UCP1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and Adiponectin (Sigma-Aldrich). Temperatures of mice were taken with a rectal thermometer (Thermoworks, American Fork, UT, USA) between 1500 and 1600 hours. For cold tolerance tests, fasted mice were individually placed in cages at 7°C and body temperatures were taken every 60 min.
Fat explants
Subcutaneous inguinal and visceral epididymal adipose tissues were cut with scissors into small pieces (20-40 mg) under aseptic conditions and incubated in high-glucose Dulbecco's modified Eagle's medium (SigmaAldrich) with or without insulin (Sigma-Aldrich). After 24 h, the release of free fatty acids into the medium was measured and the result was normalized according to fat weight.
Glucose uptake
Mice were injected following a four-hour fast with 0.75 μCi of 2-[1,2-3 H (N)]-Deoxy-D-glucose (Perkin Elmer, Boston, MA, USA), diluted in 100 μl of 0.25 g ml − 1 glucose solution via the tail vein. Twenty minutes after injection mice were killed, intracardially perfused with phosphate-buffered saline, and tissues were collected. Tissue homogenates were transferred to a scintillation vial with 1 ml of Optiphase scintillation fluid (Perkin Elmer), and samples were analyzed using a liquid scintillation counter (Beckman Coulter, Brea, CA, USA).
Gene expression
RNA was isolated with TRIzol reagent (Sigma-Aldrich) according to the manufacturer's instructions and followed by a DNAse treatment (Applied Biosystems, Foster City, CA, USA). Retrotranscription was performed according to the high-capacity cDNA retrotranscription kit instructions (Applied Biosystems). Real-time PCR was carried out with the SYBERgreen I enzyme (Applied Biosystems) in a StepOnePlus thermocyler (Applied Biosystems). β-Actin mRNA was used for normalization.
Statistical analysis
Data are expressed as mean ± s.e. Multiple groups were compared using two-way analysis of variance (ANOVA), with genotype (APOE3 versus APOE4) and diet (standard diet versus westernized high-fat diet) as the main factors. The level of significance was set at 0.05. Data were analyzed using R version 3.1.3 (http://www.r-project.org) and figures generated with GraphPad prism v.5.0 (San Diego, CA, USA).
RESULTS
APOE4 mice gain less body weight and visceral fat when fed an obesogenic diet We have previously described that when fed an obesogenic diet there is a less pronounced increase in body weight of young APOE4 mice compared with APOE3 mice. 12 To determine whether this difference was sustained in older age, we modeled dietinduced obesity (DIO) in APOE3 and APOE4 mice through chronic administration of a Western-type diet (WD) from 2 to 12 months of age. Cohorts of mice were killed after either 1, 2, 6 or 10 months on the obesogenic diet, and body weight and adipose tissue mass were measured. During the obesogenic feeding, both groups of mice increased their body weight (P o 0.0001 diet effect, two-way ANOVA; Figure 1a ). Compared with DIO-APOE3, DIO-APOE4 mice were consistently leaner throughout the diet (P o0.001 genotype effect, two-way ANOVA). DIO-APOE4 mice also had decreased epididymal fat pad mass relative to DIO-APOE3 mice (P = 0.05 genotype effect, two-way ANOVA; Figure 1b ).
To determine whether the lower body weight and visceral fat mass in APOE4 mice were due to decreased caloric intake or lipid malabsorption, we measured daily food intake and steatorrhea. However, no differences in fecal lipid excretion or daily food consumption were observed between genotypes (not shown).
Genetically obese mice carrying APOE4 show reduced weight gain We next asked whether this phenomenon of blunted weight gain in APOE4 mice was specific to a WD, or whether it would be replicated in a genetic model of obesity. Therefore, we employed the commonly used leptin-deficient mice and intercrossed them with APOE3 and APOE4 mice to obtain mice homozygous for either the APOE3 or APOE4 allele and simultaneously homozygous for the leptin mutation (ob/ob). Similar to their DIO counterparts, APOE4-ob/ob mice weighed significantly less than the APOE3-ob/ ob mice at 4 months of age ( Figure 1c ; P = 0.025, t-test). APOE4-ob/ ob mice also showed~20% less adipose tissue accumulation compared with APOE3-ob/ob mice when measured by DEXA (Figure 1d ; P = 0.044, t-test).
Plasma markers of IR and fatty-acid utilization are elevated in obese APOE4 mice Plasma cholesterol and TGs increased similarly over the course of the obesogenic diet in both DIO-APOE3 and DIO-APOE4 mice (Table 1 ; Po 0.001 for the diet effect, two-way ANOVA). Plasma glucose values remained unchanged during the diet administration for both DIO-APOE3 and DIO-APOE4 mice. However, using a two-way ANOVA model, there was an overall effect of the APOE4 genotype on both plasma insulin and the homeostatic model assessment, used to quantify IR, as both measures were significantly increased in DIO-APOE4 mice (Table 1 , P = 0.004 and P = 0.025, respectively).
Throughout the diet administration, plasma lactate, a marker of anaerobic glycolysis, was consistently higher in DIO-APOE3 mice compared with that in DIO-APOE4 mice (Table 1 ; P = 0.03 genotype effect, two-way ANOVA). Concurrently, whereas markers of stimulated fatty-acid oxidation, such as total ketone bodies and adiponectin, increased in both genotypes over the course of the diet administration, these markers were significantly higher in DIO-APOE4 compared to DIO-APOE3 mice (Table 1 ; P = 0.01 and P = 0.005 genotype effect, ketone bodies and adiponectin, respectively; two-way ANOVA).
To investigate whether adiponectin oligomer composition, in addition to total plasma adiponectin levels, differed between genotypes, plasma from DIO-APOE3 and DIO-APOE4 mice was subjected to non-reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis. No differences in the medium molecular weight oligomer were found between genotypes (Figure 1e ). However, DIO-APOE4 mice demonstrated an~60% increased high-molecular-weight (HMW) oligomer concentration compared Figure 1 . Two-month-old APOE3 and APOE4 mice were fed a WD and killed after different periods on the diet (n = 5 for each genotype at any given time point), and then total body weight (a) and gonadal adipose mass (b) were measured. # P = 0.05, ## P o0.001 for WD-APOE3 versus WD-APOE4, $ P o0.001 time on diet, two-way ANOVA. Similarly, APOE3-ob/ob and APOE4-ob/ob mice (n = 5 for each genotype) were weaned and fed for 3 months a standard laboratory diet, and body weight (c) as well as total fat mass measured by DEXA (d) were determined. n = 6 mice/genotype. *P o0.05, t-test. Plasma adiponectin levels in APOE3 and APOE4 mice that fed a WD for 2 months were analyzed by nondenaturing sodium dodecyl sulfate-PAGE into its medium molecular weight (MMW) and HMW fractions (e). A representative profile is shown in f with the ratio (HMW/MMW) between fractions (n = 8 per genotype). *P o0.05, t-test. with DIO-APOE3 mice (P = 0.04, t-test; Figures 1e and f) . Increased HMW oligomer translated into a higher HMW/medium molecular weight ratio than their DIO-APOE3 counterparts (0.94 ± 0.07 versus 0.54 ± 0.04, respectively; P o 0.001, t-test).
The genetically obese APOE3-ob/ob and APOE4-ob/ob mice showed a similar metabolic profile to their DIO counterparts. A trend showing higher plasma glucose and adiponectin levels was noted in the APOE4-ob/ob compared with APOE3-ob/ob mice (Supplementary Table; P = 0.08 for both determinations, t-test).
The ob/ob model is characterized by severe fatty liver. However, this fat accumulation showed a genotype effect and an~60% increase in hepatic TGs was detected in APOE4-ob/ob when compared with their APOE3-ob/ob counterparts (P = 0.038, t-test). Together, these results suggest that APOE4 mice are more susceptible to obesity-induced complications (IR and fatty liver) and demonstrate an increased reliance on fatty-acid consumption.
APOE4 mice show a decreased usage of carbohydrates compared to APOE3 mice We next assessed the effect of APOE on whole-body metabolic rates by measuring oxygen consumption and respiratory exchange rate using indirect calorimetry. To clearly distinguish between pre-existing APOE effects versus those specific to the obese state, we assayed (1) APOE3-ob/ob and APOE4-ob/ob mice with body weights of 61.6 ± 2.2 and 52.3 ± 2.6 g, respectively, P = 0.025 and (2) standard chow-fed APOE3 and APOE4 mice without the ob mutation, with body weights of 26.7 ± 0.5 and 24.6 ± 0.5 g, respectively, P = 0.007. Figure 2 shows the expected circadian RER fluctuations in standard chow-fed mice, with lower values of RER during fasting period (light), indicating an increased utilization of lipids as fuel. RER increased in both genotypes during the dark period, which is when mice consume most of their daily food. However, this increase was genotype-dependent as APOE4 mice had significantly lower mean RERs during this period compared with APOE3 mice (0.95 ± 0.03 versus 1.06 ± 0.03, P o0.001, t-test). A similar genotype effect was observed in the DIO-APOE3 and DIO-APOE4 mice (not shown), as well as in the genetically obese mice (Supplementary Figure 1) . APOE4-ob/ob mice had a mean RER of 0.92 ± 0.02 versus 1.00 ± 0.02 in APOE3 mice (P o0.001, t-test).
Physical activity may increase fat oxidation and reduce RER. However, the observed locomotor activity in both groups was similar throughout the experiment (Figure 2, insets) , and both groups exhibited clear diurnal activity patterns. Likewise, total oxygen consumption, reflective of total metabolic activity, did not differ between APOE3 and APOE4 mice in either background (data not shown). Together, these data suggest that both lean and obese mice with APOE4 show a preference toward a decreased usage of carbohydrates compared with those with APOE3. APOE4 mice have increased basal temperature and augmented cold tolerance Previous studies have established a link between increased fattyacid oxidation and stimulation of thermogenesis. 16 Interestingly, we observed a significant increase in basal core temperatures in standard chow-fed APOE4 compared with APOE3 mice (37.30 ± 0.68 versus 36.9 ± 0.58°C, respectively; n = 25-33, P = 0.039, t-test). We then subjected mice to a long-term (10 h) cold tolerance, and APOE4 mice were able to maintain a significantly higher core body temperature compared with APOE3 mice (Figure 3a ; P o0.05 genotype effect, repeatedmeasures ANOVA).
Upon stimulation, BAT cells degrade intracellular TG to release fatty acids, which interact with uncoupling protein-1 (UCP1), thereby leading to uncoupled mitochondrial respiration and the generation of heat. 17 Therefore, we assessed several markers of fatty-acid metabolism before and after the cold tolerance test. We observed reductions in body weight during the cold exposure, and strikingly this weight loss was almost double in APOE4 compared with APOE3 mice (Figure 3b ; 11.1% versus 6.7% of their initial body weight respectively, P o 0.05). As previously observed, plasma adiponectin was significantly higher in APOE4 compared with APOE3 mice (Figure 3c ; P o 0.001, APOE effect, two-way ANOVA), but no response to the cold was observed. Non-esterified fatty acid (NEFA) and total ketone body levels rose in both genotypes during cold exposure (Figures 3d and e; P o 0.001 for the time effect in both variables, two-way ANOVA). However, whereas higher values of both NEFA and total ketone bodies were seen in the APOE4 compared with APOE3 mice following the cold tolerance test, this difference only reached significance for ketone bodies (P = 0.002, time effect, two-way ANOVA). We next determined NEFA release in vitro in visceral and subcutaneous WAT explants extracted from standard chow-fed APOE3 and APOE4 mice. NEFA release ex vivo from APOE4 explants was higher than that of APOE3 explants, although this lipolytic effect was only significant in visceral WAT. (Figure 3f ; P = 0.090 and P = 0.046 for subcutaneous and visceral, respectively, t-test).
Together, these data suggest that APOE4 mice are more thermogenically active than their APOE3 counterparts, and that this phenomenon may be due to enhanced release of fatty acids from the visceral fat.
BAT in APOE4 mice is more metabolically and thermogenically active Cold-induced thermogenesis in vivo is mediated through BAT activation. Likewise, overfeeding as occurs with a WD is accompanied by increased thermogenesis to dissipate energy as a homeostatic mechanism against excess energy intake. 17 Therefore, we examined metabolic activity and thermogenic gene expression within the BAT of APOE3, APOE4, DIO-APOE3 and DIO-APOE4 mice. Compared with APOE3 and APOE4 mice, both DIO-APOE3 and DIO-APOE4 mice showed increased interscapular BAT mass (149 ± 16 versus 82 ± 6 mg for APOE3 mice and 151 ± 17 versus 101 ± 13 mg for APOE4, P o 0.01, diet effect, two-way ANOVA).
To assess the general metabolic activity of BAT, mice were intravenously administered a bolus of 2-[1,2-3H (N)]-Deoxy-Dglucose (2-DG). 2-DG uptake in standard diet-fed mice was approximately twice as high as in DIO mice in both white adipose (subcutaneous and visceral) and interscapular BAT. Specifically, standard diet-fed APOE3 and APOE4 mice took up twice as much 2-DG in their BAT as did DIO-E3 and DIO-E4 mice (99.9 ± 8.4 versus 40.3 ± 4.1 and 138.9 ± 12.2 versus 74.5 ± 6.6 CPM per g, respectively; Po 0.001 for diet effect, two-way ANOVA). Whereas no genotype differences in 2-DG uptake were observed in the white adipose tissue depots, BAT from both APOE4 and DIO-APOE4 mice demonstrated significantly higher rates of 2-DG uptake compared with BAT from their APOE3 counterparts (Figure 4a ; P o 0.001, genotype effect; two-way ANOVA). We next examined the expression of several genes known to be master regulators of metabolic homeostasis. Coincident with the observed metabolic pattern, mRNA levels of PPAR and PDK4 genes appeared upregulated in the skeletal muscle of DIO-APOE4 mice when compared with their DIO-APOE3 counterparts (P = 0.09 and P = 0.03, respectively, t-test; Figure 4b ). On the contrary, those genes related to muscular glucose uptake (GLUT4) and insulin sensitivity (IRS1 and IRS2) showed decreased expression in DIO-APOE4, although only the latter reached statistical significance (P = 0.02, t-test). Subsequently, metabolic regulators were also investigated in BAT. We noted a pattern of increased mRNA levels of several regulators of mitochondrial biogenesis, fatty-acid oxidation and glucose uptake (Figure 4c) . BAT from APOE4 mice showed higher expression of PGC1A, PRDM16, ADIPOR1, ADIPOR2 and UCP1, although this only reached significance for PGC1A, ADIPOR2 and UCP1 (P = 0.02, P = 0.04 and P = 0.04, respectively; t-test). Finally, given the crucial role of UCP1 in thermogenesis, we measured UCP1 protein levels within the BAT of APOE3 and APOE4 mice. When compared with DIO-APOE3 mice, UCP1 protein expression was significantly higher in the BAT of DIO-APOE4 mice (Figure 4d ; P = 0.01, t-test). Taken together, these data suggest that the APOE*4 allele is associated with an increase in the metabolic and thermogenic activity of BAT.
DISCUSSION
The polymorphic APOE has significant roles in the delivery of lipids to their target tissues. 15 However, beyond its functions in lipoprotein metabolism, research on the specific role of the APOE isoforms in energy balance is scarce. In this study, we show that mice carrying the human APOE*4 allele have a distinct metabolic profile compared with mice with the APOE*3 allele. Specifically, this APOE*4-specific profile is characterized by reductions in weight gain and visceral fat, a shift toward fatty-acid oxidation, and more metabolically and thermogenically active BAT. Obesity has reached epidemic rates worldwide, 18 and the frequency of APOE*4 carriers (~25% of the population) is relatively high. Although some studies have failed to observe an impact of the APOE genotype on body weight, 19, 20 we and others have reported an association of the APOE isoforms with body mass index in the order of APOE4 oAPOE3 oAPOE2.
14,21 Likewise, our previous research has shown that, similar to humans, mice expressing human APOE4 gain less body weight and adipose tissue than mice with APOE3 when fed a WD. 12 Whereas decreased fat mass traditionally carries positive connotations, the reduced adipogenesis in APOE4 mice, as well as APOE*4 carrying humans, appears to be detrimental. The failure to store lipids in adipose tissue is a potential contributor to obesityinduced IR and glucose intolerance among APOE4 carriers, both in mice 12 and humans. 5 In the current study, we confirm and expand upon these APOE effects on adiposity and glucose metabolism in diet-induced and genetic models of obesity, as both DIO-and ob/ob-APOE3 mice increased their WAT mass and maintained enhanced insulin sensitivity compared with their APOE4 counterparts.
In the case of defective adipose tissue expansion, more free fatty acids are typically released into the circulation to be taken up by skeletal muscle and thermogenic tissues such as BAT where they serve as a fuel. 22 Excess fatty acids are also channeled to the liver for the generation of ketone bodies. 23 Incidentally, we have previously shown impaired adipogenesis and increased steatosis in APOE4 mice with DIO. 13 Recently, a higher expression of proteins involved in lipid oxidation in skeletal muscle accompanied by activation in adipose tissue lipase has been also described in APOE4 mice. 24 This report extends these studies by showing that these phenomena should be interpreted in conjunction with an overall change in the pattern of fuel consumption. RER values reflect global fuel substrate utilization, and, typically, a RER of~0.70 indicates that fat is the predominant fuel source, whereas a RER close to 1.00 indicates carbohydrates. 25 The observed mean RER value in APOE3 mice (1.06) is likely associated with a high rate of glucose utilization and conversion into lipid, as RERs surpassing 1.0 typically only appear when glucose is channeled to de novo lipogenesis. 26 Consistent with this, APOE3 mice accumulated more white adipose tissue and showed increased body weight than APOE4 mice.
Furthermore, the shift toward lipid utilization in APOE4 mice noted above was accompanied by several metabolic features that point toward increased fatty-acid oxidation. This included increased ex vivo fatty-acid release by adipose tissue, higher basal body temperature, augmented cold tolerance and increased glucose uptake and thermogenic gene and protein expression in BAT. Interestingly, reactive oxygen species are generated during fatty-acid oxidation causing IR, 27 and APOE4 has itself been associated with increased oxidative stress (reviewed in JofreMonseny et al. 28 ). Likewise, previous reports show that uncoupling is a physiologically relevant mechanism to reduce oxidative stress in a mammalian organ of high oxidative capacity. 29 Thus, a potential hypothesis to link the thermogenic and metabolic profiles associated with APOE4 is that stimulation of lipid oxidation in APOE4 mice might increase the reactive oxygen species demand for antioxidant measures as cellular oxygen increases-thereby creating a thermoregulatory effect through UCP1 activation and heat production-which may, at least partially, increase body temperature and cold tolerance.
The phenomena described above appear to be leptin-independent, as similar phenotypes were observed in both wild-type and leptin-deficient (ob/ob) human APOE mice. On the other hand, elevations in total adiponectin and, in particular, its most active HMW multimer were observed in APOE4 mice. Some studies have previously reported that adiponectin inhibits thermogenesis and UCP1 expression via a reduction in the supply of fatty acids to be used as thermogenic substrates. 30, 31 In this study, we show that the presence of APOE4 is associated with increases in the percentage of lipid diverted to oxidation. This catabolic process releases NEFA from WAT, which can be directed to the BAT to feed, at least partially, the thermogenic process, thereby offsetting the possible inhibitory effects of adiponectin. 16 Moreover, increased expression of adiponectin receptors, which are positive regulators of UCP, 32 was measured in the BAT of APOE4 mice. It has been proposed that adiponectin receptors may have other ligands or have ligand-independent activity. 31 Thus, the observed rise in adiponectin could simply be a consequence of reduced WAT mass, and may not be directly involved in the regulation of the metabolic switch observed in APOE4 mice. This APOE4 shift, or preference, toward fatty acid rather than carbohydrate oxidation reported in this study has implications for a number of disease states in which APOE has a role, including obesity, diabetes, cardiovascular disease and AD. 33 Although this study focused on adipose tissues and whole-body fuel utilization, our results may have particularly important implications for neurodegenerative disease, specifically AD. The APOE4 genotype represents the most significant genetic risk factor for late-onset AD. 34, 35 Moreover, obesity and IR predispose individuals to cognitive impairments and an increased risk of developing dementia, 36 and this association is remarkably strong among carriers of the APOE*4 allele. 37 Furthermore, patients with AD demonstrate a functional brain IR, 6 whereas APOE4 itself has also been associated with inefficient brain glucose regulation, 38 even decades before the onset of disease, 7 suggesting that APOE4 and IR may involve shared neuropathological pathways. Interestingly, increased plasma adiponectin levels, as observed in APOE4 carriers, are an independent risk factor for the development of both all-causes of dementia in men and women and of AD in women. 39 The brain relies primarily on glucose as an energy source, and thus an inherent metabolic preference toward the usage of fats versus carbohydrates could represent a critical handicap for APOE4-expressing neurons and glia.
In summary, the presence of APOE4 changes the global metabolic profile with a shift toward fatty-acid oxidation and increased thermogenesis in mice. As BAT mass is minimal in adult humans relative to WAT, further clarifying in humans the metabolic differences observed in this study is warranted. Understanding the role of APOE in metabolism may represent a critical first step in the development of APOE-directed therapies for a large percentage of the population affected by obesity, diabetes, age-related cognitive decline, AD and cardiovascular disease.
